September 9, 2025
Rapport Announces Proposed Public Offering of Common Stock
BOSTON and SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a…
Pharmaceuticals, Biotechnology and Life Sciences
BOSTON and SAN DIEGO, Sept. 08, 2025 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a…
NEW YORK and WALTHAM, Mass., Sept. 08, 2025 (GLOBE NEWSWIRE) — Dianthus Therapeutics, Inc. (Nasdaq: DNTH), a clinical-stage biotechnology company…
Abivax Presents First Half 2025 Financial Results PARIS, France, September 8, 2025, 10:00 p.m. CEST – Abivax SA (Euronext Paris:…
GARDEN CITY, N.Y., Sept. 08, 2025 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR) (“Beyond Air” or the “Company”), a…
Persephone First-of-Its-Kind Infant Synbiotic In just over a month, 10,000 parents and caregivers joined the waitlist for Persephone’s science-driven synbiotic…
TIGARD, Ore., Sept. 08, 2025 (GLOBE NEWSWIRE) — Go North Hemp, a U.S. wholesale supplier of hemp-derived ingredients, today announced…
OSE Immunotherapeutics Provides Update on Ongoing Proceedings Ahead of Shareholders’ Annual General Meeting of September 30, 2025 NANTES, France, September…
Analysis of the FAERS database shows that the real-world abuse potential of the DORA class is very low and markedly…
DALLAS, Sept. 08, 2025 (GLOBE NEWSWIRE) — BioNTX proudly announces that John Crowley, President and CEO of the Biotechnology Innovation…
PD-L1xVEGF-A bispecific antibody pumitamig (BNT327/BMS986545) plus chemotherapy continues to show encouraging antitumor activity in patients with extensive-stage small cell lung…